Dialogue Health Technologies Inc.
DLHTFOTCHealthcare
$3.79
+$0.02(+0.59%)
Market Cap$254797554
P/E Ratio—
52W High$3.7922
52W Low$2.07
Dialogue Health Technologies Inc. (DLHTF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DLHTF · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($25.95M) | ($251.35M) | ($20.23M) | ($12.04M) | ($10.08M) |
| Depreciation & Amort. | $3.55M | $2.62M | $1.92M | $0.70M | $0.14M |
| Stock-Based Comp. | $3.47M | $2.06M | $0.29M | $0.27M | $0.24M |
| Change in Working Capital | $3.01M | ($1.73M) | ($1.20M) | ($2.26M) | ($0.93M) |
| Net Cash from Operations | ($15.57M) | ($23.28M) | ($18.41M) | ($12.98M) | ($9.74M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.45M) | ($0.74M) | ($0.94M) | ($0.60M) | ($0.76M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($24.66M) | ($4.96M) | ($5.94M) | ($1.92M) | ($0.76M) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.17M) | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | ($1.16M) | $89.71M | $42.18M | $35.46M | $14.05M |
| Free Cash Flow | |||||
| Free Cash Flow | ($16.02M) | ($24.02M) | ($19.35M) | ($13.59M) | ($10.49M) |
| FCF Margin %(computed) | -18.39% | -35.29% | -54.06% | -134.68% | -261.44% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · M
Explore more Dialogue Health Technologies Inc. data
About Dialogue Health Technologies Inc. (DLHTF) Cash Flow Statement
Dialogue Health Technologies Inc. generated operating cash flow of ($0.02B) and free cash flow of ($0.02B) for 2022 — a FCF margin of -18.39%. Capital expenditure was ($0.00B).
Frequently asked questions
DLHTF · 4 questionsDialogue Health Technologies Inc. generated free cash flow of ($0.02B) for 2022, up 33.3% year-over-year.
DLHTF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10